Biochemical, hormonal and genetic evaluation of the families of two Brazilian patients with type 2 familial partial lipodystrophy;Avaliação bioquímica, hormonal e genética das famílias de duas pacientes brasileiras portadoras de lipodistrofia parcial familiar tipo 2

Arquivos Brasileiros de Endocrinologia e Metabologia

Volumn 57, Issue 8, 2013, Pages 583-593

  Caldas, Dayse ^a   da Silva Júnior, Wellington Santana ^b   Simonetti, José Pascoal ^c   da Costa, Eliane Veiga ^b   de Farias, Maria Lucia Fleiuss ^d  

^a Instituto Estadual de Diabetes e Endocrinologia Luiz Capriglione   (Brazil)

^b STATE UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^c INSTITUTO OSWALDO CRUZ   (Brazil)

^d FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

Insulin resistance; Lamin A C; Lipodystropy; LMNA gene

Indexed keywords

BIOLOGICAL MARKER; LAMIN A; LEPTIN; LMNA PROTEIN, HUMAN;

ADOLESCENT; ADULT; ARTICLE; BLOOD; CASE REPORT; DIABETES MELLITUS; DNA SEQUENCE; FAMILIAL PARTIAL LIPODYSTROPHY; FEMALE; GENETICS; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN RESISTANCE; MIDDLE AGED; MUTATION; OVARY POLYCYSTIC DISEASE; PEDIGREE; YOUNG ADULT;

ADOLESCENT; ADULT; BIOLOGICAL MARKERS; BLOOD GLUCOSE; DIABETES MELLITUS; FEMALE; HUMANS; INSULIN RESISTANCE; LAMIN TYPE A; LEPTIN; LIPODYSTROPHY, FAMILIAL PARTIAL; MIDDLE AGED; MUTATION; PEDIGREE; POLYCYSTIC OVARY SYNDROME; SEQUENCE ANALYSIS, DNA; YOUNG ADULT;

EID: 84890746974     PISSN: 00042730     EISSN: 16779487     Source Type: Journal    
DOI: 10.1590/S0004-27302013000800002     Document Type: Article

References (20)

1. Garg A. Lipodystrophies: genetic and acquired body fat disorders. J Clin Endocrinol Metab. 2011;96(11):3313-25.
2. Bhayana S, Hegele RA. Genetic syndromes of human lipodystrophy. Can J Diab. 2002;26(4):363-8.
3. Vantyghem MC, Pigny P, Maurage CA, Rouaix-Emery N, Stojkovic T, Cuisset JM, et al. Patients with familial partial lipodystrophy of the Dunnigan type due to a LMNA R482W mutation show muscular and cardiac abnormalities. J Clin Endocrinol Metab. 2004;89(11):5337-46.
4. Broers JLV, Ramaekers FCS, Bonne G, Yaou RB, Hutchison CJ. Nuclear lamins: laminopathies and their role in premature ageing. Physiol Rev. 2006;86:967-1008.
5. Goldberg M. Import and export at the nuclear envelope. Symp Soc Exp Biol. 2004;1:115-33.
6. Herrmann H, Bar H, Kreplak L, Strelkov SV, Aebi U. Intermediate filaments: from cell architecture to nanomechanics. Nat Rev Mol Cell Biol. 2007;8:562-73.
7. Hegele RA, Anderson CM, Wang J, Jones DC, Cao H. Association between nuclear lamin A/C R482Q mutation and partial lipodystrophy with hyperinsulinemia, dyslipidemia, hypertension and diabetes. Genome Res. 2000;10:652-58.
8. Speckman RA, Garg A, Du F, Bennett L, Veile R, Arioglu E, et al. Mutational and haplotype analyses of families with familial partial lipodystrophy (Dunnigan variety) reveal recurrent missense mutations in the globular C-terminal domain of lamin A/C. Am J Hum Genet. 2000;66:1192-8.
9. Vigouroux C, Magré J, Vantyghem MC, Bourut C, Lascols O, Shackleton S, et al. Lamin A/C gene: sex-determined expression of mutations in Dunnigan-type familial partial lipodystrophy and acquired generalized lipoatrophy. Diabetes. 2000;49:1958-62.
10. Shackleton S, Lloyd DJ, Jackson SNJ, Evans R, Niermeijer MF, Singh BM, et al. LMNA, encoding lamin A/C, is mutated in partial lipodystrophy. Nat Genet. 2000;24:153-6.
11. Schmidt H, Genschel J, Baier P, Schmidt M, Ockenga J, Tietge UJ, et al. Dyslipemia in familial partial lipodystrophy caused by an R482W mutation in the LMNA gene. J Clin Endocrinol Metab. 2001;86:2289-95.
12. Cao H, Hegele RA. Nuclear lamin A/C R482Q mutation in canadian kindreds with Dunnigan-type familial partial lipodystrophy. Hum Mol Genet. 2000;9:109-12.
13. Garg A, Vinaitheerthan M, Weatherall PT, Bowcock AM. Phenotypic heterogeneity in patients with familial partial lipodystrophy (Dunnigan variety) related to the site of missense mutations in lamin A/C gene. J Clin Endocrinol Metab. 2001;86:50-65.
14. Hegele RA. LMNA mutation position predicts organ system involvement in laminopathies. Clin Genet. 2005;8:31-4.
15. Decaudain A, Vantyghem MC, Guerci B, Hécart AC, Auclair M, Reznik Y, et al. New metabolic phenotypes in laminopathies: LMNA mutations in patients with severe metabolic syndrome. J Clin Endocrinol Metab. 2007;92(12):4835-44.
16. Urbanek M, Nampiaparampil G, D'Souza J, Sefton E, Ackerman C, Legro RS, et al. The role of genetic variation in the lamin A/C gene in the etiology of polycystic ovary syndrome. J Clin Endocrinol Metab. 2009;94:2665-9.
17. Boschmann M, Engeli S, Moro C, Luedtke A, Adams F, Gorzelniak K, et al. LMNA mutations, skeletal muscle lipid metabolism, and insulin resistance. J Clin Endocrinol Metab. 2010;95(4):1634-43.
18. Haque WA, Shimomura I, Matsuzawa Y, Garg A. Serum adiponectin and leptin levels in patients with lipodystrophies. J Clin Endocrinol Metab. 2002;87:2395.
19. Park JY, Javor ED, Cochran EK, DePaoli AM, Gorden P. Long-term efficacy of leptin replacement in patients with Dunnigan-type familial partial lipodystrophy. Metabolism. 2007;56(4):508-16.
20. Hegele RA. Phenomics, lamin A/C, and metabolic disease. J Clin Endocrinol Metab. 2007;92(12):4566-8.